Drugs / ViscoGel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01578070 | Mar → Dec 2012 | — | Viscogel AB | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ViscoGel | “Pre-selected dose of ViscoGel® (from phase A) and Act-HIB® vaccine, IM (intramuscular) on day 0 of phase B.” NCT01578070 ↗ |
| Modality | Other / unclassified | “ViscoGel, a chitosan-based hydrogel” PMID 25218298 ↗ Sep 2014 |
| Route | Intramuscular | “administered as a single intramuscular injection” PMID 25218298 ↗ Sep 2014 |